TG Therapeutics Inc. diskutieren
TG Therapeutics Inc.
WKN: A1JXW7 / Symbol: TGTX / Name: TG Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
16,06 €
4,38 %
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock, up previously from $24.00.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $42.00 price target on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $10.00 to $16.00. They now have a "sell" rating on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at HC Wainwright from $34.00 to $41.00. They now have a "buy" rating on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $32.00 price target on the stock, down previously from $42.00.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $34.00 to $22.00. They now have an "overweight" rating on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $41.00 price target on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target lowered by analysts at B. Riley from $32.00 to $24.00. They now have a "buy" rating on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at JPMorgan Chase & Co. from $22.00 to $23.00. They now have an "overweight" rating on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $23.00 price target on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at HC Wainwright from $41.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at B. Riley from $24.00 to $29.00. They now have a "buy" rating on the stock.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
Ratings data for TGTX provided by MarketBeat
Neueste Beiträge
UBS_Group_AG in Amaresco Inc. A diskutieren